Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
30.77
+1.01 (+3.39%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
35,631,056
Open
30.15
Bid (Size)
30.69 (1)
Ask (Size)
30.71 (6)
Prev. Close
29.76
Today's Range
30.01 - 30.88
52wk Range
25.20 - 37.34
Shares Outstanding
5,606,688,356
Dividend Yield
5.33%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
10 Health Care Stocks Whale Activity In Today's Session
Today 13:35 EDT
Via
Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
Today 12:25 EDT
These stocks arguably deserve more respect from investors.
Via
The Motley Fool
Performance
YTD
+3.50%
+3.50%
1 Month
+9.93%
+9.93%
3 Month
+21.81%
+21.81%
6 Month
+12.01%
+12.01%
1 Year
-17.31%
-17.31%
More News
Read More
Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
Today 9:08 EDT
Via
Benzinga
Get Your Money Out of These 3 Dividend Stocks by 2025
Today 6:31 EDT
Via
InvestorPlace
What's Going On With Pfizer Stock Thursday?
July 25, 2024
Via
Benzinga
Pfizer's Options: A Look at What the Big Money is Thinking
July 25, 2024
Via
Benzinga
Check Out What Whales Are Doing With PFE
July 19, 2024
Via
Benzinga
European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
July 25, 2024
From
Pfizer Inc.
Via
Business Wire
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
From
FN Media Group LLC
Via
GlobeNewswire
7 Dividend Stocks to Hold On Tight to for the Next Decade
July 25, 2024
Via
InvestorPlace
3 Stocks That Can Help You to Get Richer in 2024 and Beyond
July 25, 2024
Via
The Motley Fool
Beware, Wegovy -- Pfizer Is Working on a Competitor
July 25, 2024
Via
The Motley Fool
Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?
July 24, 2024
Via
InvestorPlace
Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study
July 24, 2024
Via
Benzinga
This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer
July 24, 2024
Via
The Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
Via
Benzinga
Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy Candidate
July 24, 2024
From
Pfizer Inc.
Via
Business Wire
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
July 23, 2024
Via
Benzinga
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
July 23, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 23, 2024
Via
Benzinga
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
July 22, 2024
Via
Benzinga
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche
July 22, 2024
Via
The Motley Fool
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
July 21, 2024
Via
The Motley Fool
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
July 20, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.